Aeglea Biotherapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $85k | 2.2k | 37.93 |
| 2023-12-31 | $494 | 23 | 21.52 |
| 2023-09-30 | $269 | 22 | 12.27 |